Background
==========

Late gadolinium enhancement (LGE) cardiac MR can identify injured or scarred myocardium. However its prognostic implication remains unclear.

Objective
=========

We sought to quantify the risk of major adverse cardiovascular events (MACE) among patients with LGE and CAD.

Methods
=======

Two reviewers conducted a systematic search of electronic databases (MEDLINE and EMBASE) and hand searched bibliographies. Reviewers extracted data in duplicate, evaluated the quality of the studies based on a 4 point scale, and calculated pooled estimates. Out of 579 unique records screened, 115 full-text articles were assessed for eligibility. We then performed a meta-analysis on 18 eligible studies which reported on the occurrence of MACE in patients with LGE detected after a myocardial infarction.

Results
=======

A total of 4,438 patients were included in the analysis. The overall hazard ratio (HR) for MACE was 2.65 (95% confidence intervals, CI, 1.98-3.56) for the presence of any LGE, with large amounts of heterogeneity between studies (I^2^, 83.5%). Furthermore, there was a continuous relationship between risk and the amount of LGE detected. For every 10% of the left ventricular mass with LGE, the risk of MACE increased by 56% (HR 1.56/10% LGE, 95% CI 1.39-1.75; I2, 63.6%). Pre-specified meta-regression analyses revealed that the HR for MACE decreased with declining ejection fraction (p=0.02) when LGE was continuous, and was inversely related to age (p\<0.001) when LGE was binary.

Limitations
===========

Studies were heterogeneous with respect to patient characteristics and the definition of MACE, which may limit interpretability and generalizability.

Conclusions
===========

The presence and extent of LGE are independent predictors of MACE in patients with prior myocardial infarction.
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